|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
159.21 CAD |
-9.54% |
|
-8.53% | -10.47% |
Published on 05/05/2026
at 06:38 pm EDT – Modified on 05/05/2026
at 06:53 pm EDT
Publicnow
iA Financial Corporation Inc.
Interim Condensed Consolidated Financial Statements
For the first quarter of 2026
As at March 31, 2026 and 2025
Table of Contents
Consolidated Income Statements…………………………………………………………………………………………………………………………………. 2
Consolidated Comprehensive Income Statements ………………………………………………………………………………………………………….. 3
Consolidated Statements of Financial Position………………………………………………………………………………………………………………. 4
Consolidated Equity Statements ………………………………………………………………………………………………………………………………….. 5
Consolidated Cash Flows Statements…………………………………………………………………………………………………………………………… 6
Notes to Interim Condensed Consolidated Financial Statements ………………………………………………………………………………………. 7
-
› General Information …………………………………………………………………………………………………………………………………………………………… 7
-
› Changes in Accounting Policies ……………………………………………………………………………………………………………………………………………. 7
-
› Investments and Net Investment Income ………………………………………………………………………………………………………………………………… 8
-
› Fair Value of Financial Instruments and Investment Properties 10
-
› Management of Financial Risks Associated with Financial Instruments and Insurance Contracts 14
-
› Derivative Financial Instruments 16
-
› Segregated Funds Net Assets 18
-
› Insurance Contracts and Reinsurance Contracts 19
-
› Common Shares 22
-
› Preferred Shares and Other Equity Instruments 22
-
› Capital Management 23
-
› Income Taxes 23
-
› Segmented Information 24
-
› Earnings Per Common Share 25
-
› Commitments 26
-
› Event After the Reporting Period 26
-
› Comparative Figures 26
Consolidated Income Statements
Three months ended March 31
|
(unaudited, in millions of Canadian dollars, unless otherwise indicated) |
2026 |
2025 |
|
Insurance service result |
||
|
Insurance revenue (Note 8) |
$ 2,016 |
$ 1,826 |
|
Insurance service expenses |
(1,622) |
(1,465) |
|
Net income (expenses) from reinsurance contracts |
(89) |
(80) |
|
305 |
281 |
|
|
Net investment result |
||
|
Net investment income (Note 3) |
||
|
Interest and other investment income |
574 |
549 |
|
Change in fair value of investments |
(662) |
(86) |
|
(88) |
463 |
|
|
Finance income (expenses) from insurance contracts |
196 |
(366) |
|
Finance income (expenses) from reinsurance contracts |
15 |
50 |
|
(Increase) decrease in investment contract liabilities and interest on deposits |
(23) |
(41) |
|
100 |
106 |
|
|
Investment income (expenses) from segregated funds net assets |
87 |
(116) |
|
Finance income (expenses) related to segregated funds liabilities |
(87) |
116 |
|
– |
– |
|
|
100 |
106 |
|
|
Other revenues |
628 |
487 |
|
Other operating expenses |
(769) |
(615) |
|
Other financing charges |
(17) |
(18) |
|
Income before income taxes |
247 |
241 |
|
Income tax (expense) recovery (Note 12) |
(101) |
(46) |
|
Net income |
146 |
195 |
|
Dividends on preferred shares and distributions on other equity instruments (Note 10) |
(9) |
(9) |
|
Net income attributed to common shareholders |
$ 137 |
$ 186 |
|
Earnings per common share (in dollars) (Note 14) |
||
|
Basic |
$ 1.50 |
$ 1.99 |
|
Diluted |
1.49 |
1.98 |
|
Weighted average number of shares outstanding (in millions of units) (Note 14) |
||
|
Basic |
91 |
93 |
|
Diluted |
92 |
94 |
|
Dividends per common share (in dollars) (Note 9) |
0.99 |
0.90 |
|
The accompanying notes are an integral part of these Interim Condensed Consolidated Financial Statements. |
||
Consolidated Comprehensive Income Statements
Three months ended March 31
|
(unaudited, in millions of Canadian dollars) |
2026 |
2025 |
|
Net income |
$ 146 |
$ 195 |
|
Other comprehensive income, net of income taxes |
||
|
Items that may be reclassified subsequently to net income: |
||
|
Net investment hedge |
||
|
Unrealized gains (losses) on currency translation in foreign operations |
131 |
3 |
|
Hedges of net investment in foreign operations |
(94) |
(1) |
|
37 |
2 |
|
|
Items that will not be reclassified subsequently to net income: |
||
|
Remeasurement of post-employment benefits |
22 |
16 |
|
Total other comprehensive income |
59 |
18 |
|
Comprehensive income attributed to shareholders |
$ 205 |
$ 213 |
|
Income Taxes Included in Other Comprehensive Income |
||
|
Three months ended March 31 |
||
|
(unaudited, in millions of Canadian dollars) |
2026 |
2025 |
|
Income tax recovery (expense) related to: |
||
|
Items that may be reclassified subsequently to net income: |
||
|
Hedges of net investment in foreign operations |
$ 17 |
$ – |
|
Items that will not be reclassified subsequently to net income: |
||
|
Remeasurement of post-employment benefits |
(9) |
(6) |
|
Total income tax recovery (expense) included in other comprehensive income |
$ 8 |
$ (6) |
|
The accompanying notes are an integral part of these Interim Condensed Consolidated Financial Statements. |
||
|
Consolidated Statements of Financial Position |
||
|
As at March 31 |
As at December 31 |
|
|
2026 |
2025 |
|
|
(in millions of Canadian dollars) |
(unaudited) |
|
|
Assets |
||
|
Investments (Note 3) |
||
|
Cash and short-term investments |
$ 2,208 |
$ 2,262 |
|
Bonds |
30,337 |
31,080 |
|
Stocks |
7,390 |
6,504 |
|
Loans |
3,723 |
3,687 |
|
Derivative financial instruments (Note 6) |
814 |
926 |
|
Other investments |
119 |
119 |
|
Investment properties |
1,422 |
1,446 |
|
46,013 |
46,024 |
|
|
Other assets |
7,031 |
5,185 |
|
Insurance contract assets (Note 8) |
75 |
80 |
|
Reinsurance contract assets (Note 8) |
3,335 |
3,287 |
|
Fixed assets |
342 |
333 |
|
Deferred income tax assets |
813 |
775 |
|
Intangible assets |
2,279 |
2,278 |
|
Goodwill |
1,814 |
1,799 |
|
General fund assets |
61,702 |
59,761 |
|
Segregated funds net assets (Note 7) |
64,150 |
63,047 |
|
Total assets |
$ 125,852 |
$ 122,808 |
|
Liabilities |
||
|
Insurance contract liabilities (Note 8) |
$ 36,883 |
$ 37,317 |
|
Reinsurance contract liabilities (Note 8) |
2 |
– |
|
Investment contract liabilities and deposits |
8,094 |
7,620 |
|
Derivative financial instruments (Note 6) |
859 |
734 |
|
Other liabilities |
5,857 |
3,936 |
|
Deferred income tax liabilities |
401 |
392 |
|
Debentures |
1,497 |
1,496 |
|
General fund liabilities |
53,593 |
51,495 |
|
Insurance contract liabilities related to segregated funds (Note 8) |
47,550 |
46,365 |
|
Investment contract liabilities related to segregated funds |
16,600 |
16,682 |
|
Total liabilities |
$ 117,743 |
$ 114,542 |
|
Equity |
||
|
Common shares and contributed surplus |
$ 1,506 |
$ 1,530 |
|
Preferred shares and other equity instruments (Note 10) |
1,000 |
1,000 |
|
Retained earnings and accumulated other comprehensive income |
5,603 |
5,736 |
|
8,109 |
8,266 |
|
|
Total liabilities and equity |
$ 125,852 |
$ 122,808 |
|
The accompanying notes are an integral part of these Interim Condensed Consolidated Financial Statements. |
||
Consolidated Equity Statements
Preferred shares
As at March 31, 2026
Accumulated
other
Common shares
and other equity instruments
Contributed
surplus
Retained earnings
comprehensive
income Total
(unaudited, in millions of Canadian dollars) (Note 9) (Note 10)
|
Balance as at December 31, 2024 |
$ 1,524 |
$ 600 |
$ 16 |
$ 5,253 |
$ 74 |
$ 7,467 |
|
Net income |
– |
– |
– |
1,096 |
– |
1,096 |
|
Other comprehensive income |
– |
– |
– |
– |
(23) |
(23) |
|
Comprehensive income for the year |
– |
– |
– |
1,096 |
(23) |
1,073 |
|
Equity transactions |
||||||
|
Transfer of post-employment benefits |
– |
– |
– |
47 |
(47) |
– |
|
Stock option plan |
– |
– |
4 |
– |
– |
4 |
|
Stock options exercised |
– |
– |
(4) |
– |
– |
(4) |
|
Issuance of common shares |
22 |
– |
– |
– |
– |
22 |
|
Redemption of common shares |
(32) |
– |
– |
(267) |
– |
(299) |
|
Issuance of preferred shares |
– |
400 |
– |
(4) |
– |
396 |
|
Dividends on common shares |
– |
– |
– |
(350) |
– |
(350) |
|
Dividends on preferred shares and distributions |
||||||
|
on other equity instruments |
– |
– |
– |
(43) |
– |
(43) |
|
(10) |
400 |
– |
(617) |
(47) |
(274) |
|
|
Balance as at December 31, 2025 |
1,514 |
1,000 |
16 |
5,732 |
4 |
8,266 |
|
Net income |
– |
– |
– |
146 |
– |
146 |
|
Other comprehensive income |
– |
– |
– |
– |
59 |
59 |
|
Comprehensive income for the period |
– |
– |
– |
146 |
59 |
205 |
|
Equity transactions |
||||||
|
Transfer of post-employment benefits |
– |
– |
– |
22 |
(22) |
– |
|
Stock option plan |
– |
– |
1 |
– |
– |
1 |
|
Issuance of common shares |
2 |
– |
– |
– |
– |
2 |
|
Redemption of common shares |
(27) |
– |
– |
(239) |
– |
(266) |
|
Dividends on common shares |
– |
– |
– |
(90) |
– |
(90) |
|
Dividends on preferred shares and distributions on |
||||||
|
other equity instruments |
– |
– |
– |
(9) |
– |
(9) |
|
(25) |
– |
1 |
(316) |
(22) |
(362) |
|
|
Balance as at March 31, 2026 |
$ 1,489 |
$ 1,000 |
$ 17 |
$ 5,562 |
$ 41 |
$ 8,109 |
The accompanying notes are an integral part of these Interim Condensed Consolidated Financial Statements.
Consolidated Cash Flows Statements
Three months ended March 31
|
(unaudited, in millions of Canadian dollars) |
2026 |
2025 |
|
Cash flows from operating activities |
||
|
Income before income taxes |
$ 247 |
$ 241 |
|
Other financing charges |
17 |
18 |
|
Income taxes paid, net of refunds |
(394) |
(170) |
|
Operating activities not affecting cash: |
||
|
Expenses (income) from insurance contracts |
(590) |
5 |
|
Expenses (income) from reinsurance contracts |
74 |
30 |
|
Expenses (income) from investment contracts and interest on deposits |
23 |
41 |
|
Unrealized losses (gains) on investments |
664 |
89 |
|
Provision for credit losses |
17 |
24 |
|
Other depreciation |
104 |
86 |
|
Other items not affecting cash |
27 |
34 |
|
Operating activities affecting cash: |
||
|
Sales, maturities and repayments on investments |
17,083 |
12,751 |
|
Purchases of investments |
(17,681) |
(12,782) |
|
Change in assets/liabilities related to insurance contracts |
86 |
264 |
|
Change in assets/liabilities related to reinsurance contracts |
(75) |
(97) |
|
Change in liabilities related to investment contracts and deposits |
451 |
108 |
|
Other items affecting cash |
348 |
229 |
|
Net cash from (used in) operating activities |
401 |
871 |
|
Cash flows from investing activities |
||
|
Acquisition of businesses, net of cash |
(15) |
(52) |
|
Net purchases of fixed and intangible assets |
(75) |
(50) |
|
Net cash from (used in) investing activities |
(90) |
(102) |
|
Cash flows from financing activities |
||
|
Issuance of common shares |
2 |
5 |
|
Redemption of common shares (Note 9) |
(261) |
(29) |
|
Redemption of debentures |
– |
(400) |
|
Reimbursement of lease liabilities |
(7) |
(5) |
|
Dividends paid on common shares |
(90) |
(84) |
|
Dividends paid on preferred shares and distributions on other equity instruments |
(12) |
(12) |
|
Interest paid on debentures |
(11) |
(16) |
|
Interest paid on lease liabilities |
(2) |
(1) |
|
Net cash from (used in) financing activities |
(381) |
(542) |
|
Foreign currency gains (losses) on cash |
6 |
1 |
|
Increase (decrease) in cash and short-term investments |
(64) |
228 |
|
Cash and short-term investments at beginning1 |
2,272 |
1,566 |
|
Cash and short-term investments at end |
$ 2,208 |
$ 1,794 |
|
Supplementary information: |
||
|
Cash |
$ 1,884 |
$ 1,227 |
|
Short-term investments including cash equivalents |
324 |
567 |
|
Total cash and short-term investments |
$ 2,208 |
$ 1,794 |
1 The cash and short-term investments at the beginning of the three months ended March 31, 2026 reflects the application of the amendment to IFRS 9 on January 1, 2026, and consequently the amount differs from the cash and short-term investments at end previously published as at December 31, 2025. For information on the amendment to IFRS 9, refer to Note 2 to these Interim Condensed Consolidated Financial Statements.
The accompanying notes are an integral part of these Interim Condensed Consolidated Financial Statements.
Notes to Interim Condensed Consolidated Financial Statements
Three months ended March 31, 2026 and 2025 (unaudited) (in millions of Canadian dollars, unless otherwise indicated)
-
› General Information
iA Financial Corporation Inc. (iA Financial Corporation) is a holding company listed on the Toronto Stock Exchange and incorporated under the Business Corporations Act (Quebec). iA Financial Corporation and its subsidiaries (the “Company”) offer a wide range of life and health insurance products, savings and retirement plans, mutual funds, securities, loans, auto and home insurance, creditor insurance, replacement insurance, replacement warranties, extended warranties and other ancillary products for dealer services and other financial products and services. The Company’s products and services are offered on both an individual and group basis and extend throughout Canada and the United States.
The Company’s Interim Condensed Consolidated Financial Statements (the “Financial Statements”) are prepared on the basis of IFRS® Accounting Standards in accordance with IAS 34 Interim Financial Reporting, issued by the International Accounting Standards Board (IASB). These Financial Statements do not contain all the information required in a complete annual financial statement and should be read in conjunction with the Consolidated Financial Statements for the year ended December 31, 2025, which are included in the 2025 Annual Report. The material accounting policies used to prepare these Financial Statements are consistent with those found in the 2025 Annual Report, except for items mentioned in Note 2.
The publication of these Financial Statements was authorized by the Company’s Board of Directors on May 5, 2026.
-
› Changes in Accounting Policies
New Accounting Policies Applied to Financial Statements beginning on or after January 1, 2026.
Standards or amendments Description of the standards or amendments and impacts on financial statements of the Company
IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures
Description: On May 30, 2024, the IASB published an amendment to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures.
Amendments to the Classification and Measurement of Financial Instruments introduces an accounting policy choice relating to the derecognition of financial liabilities settled through electronic payment systems, clarifies the classification and characteristics of some financial asset types and adds new disclosure requirements regarding investments in equity instruments designated at fair value through other comprehensive income and financial instruments with contingent features, including environmental, social and corporate governance events.
Impact: In accordance with the provisions of the amendment, the Company has applied it on a modified retrospective basis as at January 1, 2026, and as a result, the comparative figures are not restated. The effect is limited to the accounting treatment related to the derecognition of certain financial liabilities which led, on January 1, 2026, to an increase of $10 in Cash and short-term investments and an increase in Other liabilities of the same amount. This had no impact on the equity of the Company.
Annual Improvements to IFRS Accounting Standards 2024-2025 Cycle
Description: On July 18, 2024, the IASB published the Annual Improvements to IFRS Accounting Standards 2024-2025 Cycle. The Annual Improvements clarify situations specific to five standards:
The provisions of these improvements apply prospectively.
Impact: No impact on the Company’s financial statements.
-
IFRS 1 First-time Adoption of International Financial Reporting Standards related to the fact that an entity which had designated a transaction as hedge accounting before the date of transition to IFRS Accounting Standards must meet the qualifying criteria of IFRS 9 Financial Instruments to reflect it in its opening IFRS statement of financial position. Otherwise, the entity should discontinue the hedge accounting;
-
IFRS 7 Financial Instruments: Disclosures related to the fact that an entity which is disclosing a gain or a loss on derecognition relating to financial assets in which the entity has continuing involvement shall disclose whether the fair value measurements included significant unobservable inputs as described in the “fair value hierarchy” requirements in IFRS 13 Fair Value Measurement;
-
IFRS 9 Financial Instruments related to the fact that when a lease liability is derecognized by a lessee, the difference between the carrying amount of the extinguished liability and the consideration paid are recognized in profit or loss. The amendment also specifies that the initial measurement of trade receivables must be in accordance with “the amount determined by applying IFRS 15 Revenue from Contracts with Customers” instead of “at their transaction price”, as previously mentioned in IFRS 9;
-
IFRS 10 Consolidated Financial Statements related to the fact that when assessing control, a party might be a “de facto agent” when those that direct the activities of the investor have the ability to direct that party to act on the investor’s behalf;
-
IAS 7 Statement of Cash Flows related to the fact that the term “cost method” replaces the term “at cost” regarding the reporting requirements in the statement of cash flows for investments in subsidiaries, associates and joint ventures since the term “cost method” is no longer defined in IFRS Accounting Standards.
-
-
› Investments and Net Investment Income
-
Carrying Value and Fair Value
As at March 31, 2026
(in millions of dollars)
At fair value through
profit or loss
At amortized
cost
Other
Total
Fair value
Cash and short-term investments
$ 323
$ 1,885
$ – $
2,208
$ 2,208
Bonds
Governments
7,743
–
–
7,743
Municipalities
972
–
–
972
Corporate and other
21,622
–
–
21,622
30,337
–
–
30,337
30,337
Stocks
Common
4,863
–
–
4,863
Preferred
484
–
–
484
Stock indexes
390
–
–
390
Investment fund units
1,653
–
–
1,653
7,390
–
–
7,390
7,390
Loans
Mortgages
Insured mortgages
Multi-residential
609
–
–
609
Non-residential
1
–
–
1
610
–
–
610
Conventional mortgages
Multi-residential 215
–
–
215
Non-residential 279
–
–
279
494
–
–
494
1,104
–
–
1,104
Corporate loans
280
–
–
280
Car loans
–
1,450
–
1,450
Other loans
–
889
–
889
1,384
2,339
–
3,723
3,711
Derivative financial instruments
814
–
–
814
814
Other investments
46
3
70
119
119
Investment properties
–
–
1,422
1,422
1,456
Total investments
$ 40,294
$ 4,227
$ 1,492
$ 46,013
$ 46,035
As at December 31, 2025
(in millions of dollars)
At fair value through
profit or loss
At amortized
cost
Other
Total
Fair value
Cash and short-term investments
$ 308
$ 1,954
$ – $
2,262
$ 2,262
Bonds
Governments
7,833
–
–
7,833
Municipalities
1,028
–
–
1,028
Corporate and other
22,219
–
–
22,219
31,080
–
–
31,080
31,080
Stocks
Common
3,996
–
–
3,996
Preferred
461
–
–
461
Stock indexes
400
–
–
400
Investment fund units
1,647
–
–
1,647
6,504
–
–
6,504
6,504
Loans
Mortgages
Insured mortgages
Multi-residential
694
–
–
694
Non-residential
1
–
–
1
695
–
–
695
Conventional mortgages
Multi-residential 198
–
–
198
Non-residential 264
–
–
264
462
–
–
462
1,157
–
–
1,157
Corporate loans
250
–
–
250
Car loans
–
1,450
–
1,450
Other loans
–
830
–
830
1,407
2,280
–
3,687
3,675
Derivative financial instruments
926
–
–
926
926
Other investments
45
4
70
119
119
Investment properties
–
–
1,446
1,446
1,480
Total investments
$ 40,270
$ 4,238
$ 1,516
$ 46,024
$ 46,046
Other investments include bonds, common stocks and short-term investments that are restricted investments, notes receivable and investments in associates and joint ventures. Bonds, common stocks and short-term investments that are restricted investments are classified at fair value through profit or loss. Notes receivable are classified at amortized cost. Investments in associates and joint ventures, accounted for according to the equity method, are presented in the Other column.
The fair value of investment properties includes the carrying value of investment properties accounted for at fair value and the fair value of linearization of rents accounted for in Other Assets.
Financial Assets Used in Fair Value Hedging
Interest Rate Risk Hedging
The Company designated a portion of its bonds in a fair-value hedge relationship in order to reduce its exposure to changes in interest rates on financial liabilities classified as financial liabilities at amortized cost. The Company uses bonds that have maturities of less than 1 year to 8 years as at March 31, 2026 (less than 1 year to 8 years as at December 31, 2025). The notional amount of the bonds is $603 as at March 31, 2026 ($629 as at December 31, 2025), while the carrying
value and the fair value of the bonds are $606 ($640 as at December 31, 2025). For the three months ended March 31, 2026, the Company recognized a loss of $1 on the hedging instruments (gain of $5 for the three months ended March 31, 2025) and a gain of $4 on the hedged items (loss of $1 for the three months ended March 31, 2025). For the three months ended March 31, 2026, the Company recognized an ineffectiveness of $3 ($4 for the three months ended March 31, 2025).
-
Investments in Associates and Joint Ventures
The Company holds interests ranging from 25% to 29% as at March 31, 2026 (25% to 29% as at December 31, 2025). The carrying value of these investments as at March 31, 2026 is $70 ($70 as at December 31, 2025). The share of net income and comprehensive income for the three months ended March 31, 2026 corresponds to a profit of less than $1 (profit of $1 for the three months ended March 31, 2025).
-
Net Investment Income
Three months ended March 31
(in millions of dollars)
2026
2025
Interest and other investment income
Interest
$ 469
$ 455
Dividends
134
113
Derivative financial instruments
(23)
(17)
Net rental income
16
22
Provision for credit losses
(17)
(24)
Other income and expenses
(5)
–
574
549
Change in fair value of investments
Cash and short-term investments
2
3
Bonds
(382)
283
Stocks
13
(59)
Loans
(5)
14
Derivative financial instruments
(286)
(317)
Investment properties
(4)
(11)
Other
–
1
(662)
(86)
Total net investment income
$ (88)
$ 463
-
-
› Fair Value of Financial Instruments and Investment Properties
Methods and assumptions used to estimate fair values of financial instruments and investment properties are disclosed in Note 6 of the Company’s Consolidated Financial Statements for the year ended December 31, 2025.
Fair Value Hierarchy
Disclosures regarding financial instruments and investment properties must be presented as a hierarchy that categorizes the inputs to valuation models used to measure the fair value of financial assets and financial liabilities. The hierarchy gives the highest priority to readily available unadjusted quoted prices in active markets for identical assets or liabilities and lowest priority to unobserved inputs. The three levels of the hierarchy are described below:
Level 1 – Valuation based on quoted prices in active markets (unadjusted) for identical assets or liabilities. Level 1 financial instruments are composed, among other things, of stocks traded on the market.
Level 2 – Valuation model based on inputs other than quoted prices included in Level 1 that are observable on the market for the asset or liability, either directly or indirectly. Level 2 financial instruments are composed, among other things, of bonds and private debts.
Level 3 – Valuation model based on valuation techniques that use significant unobservable market parameters and that reflect management’s best estimates.
Level 3 financial instruments are composed, among other things, of private equity.
If a financial instrument classified as Level 1 subsequently ceases to be actively traded, it is reclassified into Level 2. If the measurement of its fair value requires the use of significant unobservable inputs, it is directly reclassified into Level 3.
Assets
As at March 31,
2026
(in millions of dollars)
Level 1
Level 2
Level 3
Total
Recurring fair value measurements
Cash and short-term investments
$ –
$ 323
$ –
$ 323
Bonds
Governments
–
7,743
–
7,743
Municipalities
–
972
–
972
Corporate and other
–
21,307
315
21,622
–
30,022
315
30,337
Stocks
3,959
334
3,097
7,390
Mortgages
–
1,104
–
1,104
Corporate loans
–
–
280
280
Derivative financial instruments
274
539
1
814
Other investments
–
46
–
46
Investment properties
–
–
1,422
1,422
General fund investments recognized at fair value
4,233
32,368
5,115
41,716
Other assets
–
66
–
66
Segregated funds financial instruments
53,441
9,403
1,322
64,166
Total financial assets at fair value
$ 57,674
$ 41,837
$ 6,437
$ 105,948
As at December 31, 20251
(in millions of dollars)
Level 1
Level 2
Level 3
Total
Recurring fair value measurements
Cash and short-term investments
$ –
$ 308
$ –
$ 308
Bonds
Governments
–
7,833
–
7,833
Municipalities
–
1,028
–
1,028
Corporate and other
–
21,894
325
22,219
–
30,755
325
31,080
Stocks
3,189
331
2,984
6,504
Mortgages
–
1,157
–
1,157
Corporate loans
–
–
250
250
Derivative financial instruments
219
706
1
926
Other investments
3
42
–
45
Investment properties
–
–
1,446
1,446
General fund investments recognized at fair value
3,411
33,299
5,006
41,716
Other assets
–
65
–
65
Segregated funds financial instruments
52,401
9,242
1,291
62,934
Total financial assets at fair value
$ 55,812
$ 42,606
$ 6,297
$ 104,715
1 During the three months ended March 31, 2026, the Company revised the presentation of fair value hierarchy information to more accurately represent the observability of inputs used in valuation models and to better reflect practices observed on the market. Data for the year ended December 31, 2025 have been reclassified to comply with the current period’s presentation. An amount of
$4,223 of corporate bonds, an amount of $84 of governments bonds and an amount of $95 of segregated funds financial instruments have therefore been reclassified from Level 3 to Level 2 as at December 31, 2025. These reclassifications had no impact on the net income of the Company.
There were no transfers from Level 1 to Level 2 during the three months ended March 31, 2026 (none for the year ended December 31, 2025). There were no transfers from Level 2 to Level 1 during the three months ended March 31, 2026 (none for the year ended December 31, 2025).
There were no transfers from Level 2 to Level 3 during the three months ended March 31, 2026 ($11 for the year ended December 31, 2025). The transfers for the year ended December 31, 2025 were related to the fair value of bonds whose price had remained unchanged for more than 30 days which, according to the Company’s internal policy, resulted in a transfer. There were no transfers from Level 3 to Level 2 during the three months ended March 31, 2026 (none for the year ended December 31, 2025).
There were no transfers from Level 1 to Level 3 during the three months ended March 31, 2026 (none for the year ended December 31, 2025). There were no transfers from Level 3 to Level 1 during the three months ended March 31, 2026 (none for the year ended December 31, 2025).
During the three months ended March 31, 2026, the Company did not reclassify properties from own-use to investment properties, in relation to a change in use. For the year ended December 31, 2025, the fair value of properties reclassified from own-use to investment properties, which are classified as Level 3, was assessed at $44. The reclassifications did not have a significant impact on the Company’s Consolidated Comprehensive Income Statements.
The Company presents the transfers between hierarchy levels and reclassifications at the quarter-end fair value for the quarter during which the transfer occurred. The following tables present assets recognized at fair value evaluated according to Level 3 parameters:
Three months ended March 31, 2026
Transfers
Total unrealized gains (losses) included in net
Balance as at
Gains (losses)
into (out of) income on
(in millions of dollars)
December 31,
2025
included in
net income
Purchases
Sales and
settlements
Level 3 and Balance as at
reclassifications March 31, 2026
investments
still held
Bonds
$ 325
$ (6)
$ –
$ (4)
$ – $ 315
$ (8)
Stocks
2,984
26
177
(90)
– 3,097
25
Corporate loans
250
3
39
(12)
– 280
(1)
Derivative financial
instruments
1
–
–
–
–
1
–
Investment properties
1,446
(4)
14
(34)
–
1,422
(5)
General fund investments
recognized at fair value
5,006
19
230
(140)
–
5,115
11
Segregated funds financial
instruments
1,291
8
28
(5)
– 1,322
6
Total
$ 6,297
$ 27
$ 258
$ (145)
$ – $ 6,437
$ 17
Year ended December 31, 20251
Transfers
Total unrealized gains (losses) included in net
Balance as at December 31,
Gains (losses) included in
into (out of)
Sales and Level 3 and
Balance as at December 31,
income on investments
(in millions of dollars)
2024
net income
Purchases
settlements
reclassifications
2025
still held
Bonds
$ 326
$ (18)
$ 38
$ (32)
$ 11
$ 325
$ (14)
Stocks
2,501
32
664
(213)
–
2,984
48
Corporate loans
–
1
249
–
–
250
1
Derivative financial
instruments
–
–
1
–
–
1
–
Investment properties
1,519
(61)
46
(102)
44
1,446
(62)
General fund investments
recognized at fair value
4,346
(46)
998
(347)
55
5,006
(27)
Segregated funds financial
instruments
1,155
77
503
(444)
–
1,291
(45)
Total
$ 5,501
$ 31
$ 1,501
$ (791)
$ 55
$ 6,297
$ (72)
1 During the three months ended March 31, 2026, the Company revised the presentation of fair value hierarchy information to more accurately represent the observability of inputs used in valuation models and to better reflect practices observed on the market. Consequently, data for the year ended December 31, 2025 have been reclassified to comply with the current period’s presentation. These reclassifications had no impact on the net income of the Company.
During the three months ended March 31, 2026, an amount of $6 ($46 for the year ended December 31, 2025) presented in Purchases for investment properties corresponds to capitalizations to Investment properties.
Gains (losses) included in net income and Total unrealized gains (losses) included in net income on investments still held are presented in Net investment income in the Income Statement, except for those related to segregated funds net assets, which are presented in Investment income (expenses) from segregated funds net assets in the Income Statement.
Valuation for Level 3 Assets
The main unobservable input used in valuation of bonds and corporate loans as at March 31, 2026 corresponds to credit and liquidity risk premiums ranging from 1.02% to 6.50% (0.70% to 6.50% as at December 31, 2025). The credit and liquidity risk premiums are the difference between the expected yield of an asset and the risk-free rate of return. The difference is called a spread and represents an extra compensation for the risk of default of the borrower and the lack of active markets to sell the financial assets. If all other factors remain constant, a decrease (increase) in credit and liquidity risk premiums will lead to an increase (decrease) in fair value of bonds and corporate loans.
The main unobservable input used in valuation of stocks as at March 31, 2026 corresponds to 100% of the net asset value of the shares owned by the Company (100% as at December 31, 2025), which is provided by the general partner of the limited partnership or the manager of the funds. The net asset value is the estimated fair value of the asset minus the fair value of the liability divided by the number of shares outstanding of a limited partnership or a fund.
The main unobservable inputs used in the valuation of the investment properties as at March 31, 2026 are the discount rate, which is between 5.75% and 8.75% (5.75% and 9.00% as at December 31, 2025) and the terminal capitalization rate, which is between 5.50% and 7.75% (5.25% and 7.75% as at December 31, 2025). The discount rate is based on market activity by type of building and by location and reflects the expected rate of return to be realized on investments over the next 10 years. The terminal capitalization rate is based on market activity by type of building and by location and reflects the expected rate of return to be realized on investments over the remaining life after the 10-year period. If all other factors remain constant, a decrease (increase) in the discount rate and terminal capitalization rate will lead to an increase (decrease) in fair value of investment properties.
Fair Value Disclosed in the Notes
The Company classifies and measures certain financial instruments at amortized cost. The fair value of these financial instruments is disclosed in the notes. The following tables show the hierarchy level of such fair values:
As at March 31, 2026
(in millions of dollars)
Level 1
Level 2
Level 3
Total
Classified at amortized cost
Car loans and other loans
$ –
$ 2,327
$ –
$ 2,327
Total of assets whose fair value is disclosed in the notes
$ –
$ 2,327
$ –
$ 2,327
As at December 31, 2025
(in millions of dollars)
Level 1
Level 2
Level 3
Total
Classified at amortized cost
Car loans and other loans
$ –
$ 2,268
$ –
$ 2,268
Total of assets whose fair value is disclosed in the notes
$ –
$ 2,268
$ –
$ 2,268
Financial Liabilities
The following tables present the fair value of financial liabilities measured at fair value on a recurring basis and those whose fair value is disclosed in a note by hierarchy level:
As at March 31, 2026
(in millions of dollars)
Level 1
Level 2
Level 3
Total
Recurring fair value measurements
Other liabilities
Short-selling securities
$ –
$ 499
$ – $
499
Securities sold under repurchase agreements
–
1,951
–
1,951
Securitization liabilities
–
6
–
6
Derivative financial instruments
103
756
–
859
Investment contract liabilities and deposits
–
1,173
–
1,173
Total of liabilities classified at fair value through profit or loss
$ 103
$ 4,385
$ – $
4,488
Classified at amortized cost
Other liabilities
Mortgage debt
$ –
$ 2
$ – $
2
Debentures
–
1,515
–
1,515
Investment contract liabilities and deposits
–
6,860
–
6,860
Investment contract liabilities related to segregated funds
–
16,600
–
16,600
Total of liabilities classified at amortized cost
$ –
$ 24,977
$ – $
24,977
As at December 31, 2025
(in millions of dollars)
Level 1
Level 2
Level 3
Total
Recurring fair value measurements
Other liabilities
Short-selling securities
$ –
$ 452
$ – $
452
Securities sold under repurchase agreements
–
988
–
988
Securitization liabilities
–
6
–
6
Derivative financial instruments
65
669
–
734
Investment contract liabilities and deposits
–
1,101
–
1,101
Total of liabilities classified at fair value through profit or loss
$ 65
$ 3,216
$ – $
3,281
Classified at amortized cost
Other liabilities
Mortgage debt
$ –
$ 2
$ – $
2
Debentures
–
1,524
–
1,524
Investment contract liabilities and deposits
–
6,435
–
6,435
Investment contract liabilities related to segregated funds
–
16,682
–
16,682
Total of liabilities classified at amortized cost
$ –
$ 24,643
$ – $
24,643
-
› Management of Financial Risks Associated with Financial Instruments and Insurance Contracts
Effective risk management rests on identifying, assessing, measuring, understanding, managing, monitoring and communicating the risks to which the Company is exposed to in the course of its operations. Risk management is comprised of a series of objectives, policies and procedures that are approved by the Board of Directors and enforced by managers. The main risk management policies and procedures are subject to review annually, or more frequently when deemed relevant. More information regarding the principles, responsibilities, key measures and management practices of the Company’s risk management of financial instruments is provided in the shaded portion of the “Risk Management” section of the 2025 Management’s Discussion and Analysis, and any relevant updates are presented in the “Risk Management and Sensitivities – Update” section of the Management’s Discussion and Analysis for the First Quarter of 2026. Those shaded portions are considered an integral part of these financial statements.
Credit Risk
Credit risk represents the risk of financial loss due to a borrower’s or a counterparty’s failure to repay its obligation when due.
-
Credit Quality Indicators Bonds by Investment Grade
(in millions of dollars)
As at March 31, 2026
As at December 31, 2025
AAA
$ 1,716
$ 1,568
AA
8,048
8,378
A
10,845
11,240
BBB
9,532
9,693
BB and lower
196
201
Total
$ 30,337
$ 31,080
The Company prepares an assessment of the quality of the investment if the evaluation is not available from a credit rating agency. Bonds that have been internally evaluated represent an amount of $3,776 as at March 31, 2026 ($3,573 as at December 31, 2025).
Loans
(in millions of dollars)
As at March 31, 2026
As at December 31, 2025
Insured mortgages
$ 610
$ 695
Conventional mortgages
494
462
Corporate loans1
280
250
Car loans and other loans
2,339
2,280
Total
$ 3,723
$ 3,687
1 Corporate loans have an investment grade of BB and lower.
The credit quality of loans is assessed internally, on a regular basis, when the review of the portfolio is carried out.
-
Allowance for Credit Losses Allowance for Credit Losses by Stage
The following tables present the gross carrying amount and the allowance for credit losses related to car loans by stage:
As at March 31, 2026
Non-impaired
Impaired
(in millions of dollars)
Stage 1
Stage 2
Stage 3
Total
Car loans1
Low risk2
$ 1,256
$ 226
$ –
$ 1,482
Medium risk2
20
6
–
26
High risk2
3
–
–
3
Impaired
–
–
18
18
Gross carrying amount
1,279
232
18
1,529
Allowance for credit losses
45
22
12
79
Carrying amount
$ 1,234
$ 210
$ 6
$ 1,450
As at December 31, 2025
Non-impaired
Impaired
(in millions of dollars)
Stage 1
Stage 2
Stage 3
Total
Car loans1
Low risk2
$ 1,254
$ 230
$ –
$ 1,484
Medium risk2
22
7
–
29
High risk2
2
–
–
2
Impaired
–
–
20
20
Gross carrying amount
1,278
237
20
1,535
Allowance for credit losses
45
28
12
85
Carrying amount
$ 1,233
$ 209
$ 8
$ 1,450
1 The credit risk rating is reflective of a nonprime lender’s risk perception.
2 Low risk is considered near prime, medium risk is nonprime and high risk is subprime.
For the three months ended March 31, 2026, the provision for credit losses related to car loans was $17 ($24 for the three months ended March 31, 2025). Considering their nature, other loans have a negligible allowance for credit losses due to their low credit risk.
-
-
› Derivative Financial Instruments
The Company is an end user of derivative financial instruments in the normal course of managing exposure to fluctuations in interest rates, currency exchange rates and fair values of investments. Derivative financial instruments are financial contracts whose value is derived from underlying interest rates, exchange rates, other financial instruments or indexes.
The notional amount represents the amount to which a rate or price is applied to determine the cash flows to be exchanged periodically and does not represent direct credit exposure. Maximum credit risk is the estimated cost of replacing derivative financial instruments that have a positive value should the counterparty default. The maximum credit risk of derivative financial instruments as at March 31, 2026 is $814 ($926 as at December 31, 2025). The Company’s exposure at the end of each reporting period is limited to the risk that a counterparty does not honour the terms of a derivative financial instrument.
As at March 31, 2026
Notional amount Fair value
(in millions of dollars)
Less than 1 year
1 to 5 years
Over 5 years
Total
Positive
Negative
Equity contracts
Swaps
$ 2,387
$ 9
$ 34
$ 2,430
$ 30
$ (28)
Futures
377
–
–
377
–
–
Options
8,345
–
–
8,345
296
(112)
Currency contracts
Swaps
50
365
7,307
7,722
252
(135)
Futures
3
–
–
3
–
–
Forwards
8,065
–
–
8,065
21
(107)
Options
72
–
–
72
–
–
Interest rate contracts
Swaps
525
3,892
12,331
16,748
210
(344)
Futures
207
–
–
207
–
–
Forwards
10,882
–
–
10,882
4
(133)
Options
46
–
–
46
–
–
Other derivative contracts
1
2
–
3
1
–
Total
$ 30,960
$ 4,268
$ 19,672
$ 54,900
$ 814
$ (859)
As at December 31, 2025
Notional amount Fair value
(in millions of dollars)
Less than 1 year
1 to 5 years
Over 5 years
Total
Positive
Negative
Equity contracts
Swaps
$ 1,850
$ 5
$ 42
$ 1,897
$ 20
$ (29)
Futures
319
–
–
319
–
–
Options
6,726
–
–
6,726
234
(70)
Currency contracts
Swaps
68
246
7,245
7,559
329
(80)
Forwards
8,904
–
–
8,904
127
(20)
Options
259
–
–
259
2
(2)
Interest rate contracts
Swaps
609
3,924
11,333
15,866
206
(379)
Futures
27
–
–
27
–
–
Forwards
9,976
–
–
9,976
7
(154)
Other derivative contracts
–
2
–
2
1
–
Total
$ 28,738
$ 4,177
$ 18,620
$ 51,535
$ 926
$ (734)
As at March 31, 2026
Notional amount
Fair value
(in millions of dollars)
Positive
Negative
Derivative financial instruments not designated as hedge accounting
$ 49,027
$ 725
$ (766)
Net investment hedge
5,865
86
(93)
Cash flow hedge
Market risk
8
3
–
Total of derivative financial instruments
$ 54,900
$ 814
$ (859)
As at December 31, 2025
Notional amount
Fair value
(in millions of dollars)
Positive
Negative
Derivative financial instruments not designated as hedge accounting
$ 48,396
$ 871
$ (734)
Net investment hedge
3,131
50
–
Cash flow hedge
Market risk
8
5
–
Total of derivative financial instruments
$ 51,535
$ 926
$ (734)
Net Investment Hedge
As at March 31, 2026, forward contracts and currency swaps, designated as hedges of net investments in foreign operations with a functional currency other than the functional currency of the Company, have maturities of less than 1 year for forward contracts (less than 1 year as at December 31, 2025) and maturities of less than 1 year to 38 years for currency swaps (none as at December 31, 2025). The average CAD/USD exchange rate is 0.7332 for forward contracts (0.7174 as at December 31, 2025) and 0.7606 for currency swaps (none as at December 31, 2025). The effective portion of changes in fair value is recorded in Other comprehensive income, as is the foreign currency translation of the net investment in a foreign operation. For the three months ended March 31, 2026 and 2025, the Company did not recognize any ineffectiveness.
Cash Flow Hedge
Market Risk Hedging
As at March 31, 2026, the Company uses a cash flow hedging relationship in order to manage its exposure to volatility of market prices on forecast transactions. The Company uses swap contracts that have maturities of 2 years or less (2 years or less as at December 31, 2025). For the three months ended March 31, 2026 and 2025, the Company did not recognize any ineffectiveness.
-
› Segregated Funds Net Assets
The table below comprises the underlying items for insurance contracts with direct participation features related to segregated funds as well as those for investment contracts related to segregated funds, which is the segregated funds net assets, and shows the composition. The fair value of the underlying items for insurance contracts with direct participation features, which are calculated under the variable fee approach, is equivalent to the Insurance contract liabilities related to segregated funds in Note 8 “Insurance Contracts and Reinsurance Contracts”, and the fair value of the underlying items for investment contracts related to segregated funds, which are accounted for at amortized cost, is equivalent to the Investment contract liabilities related to segregated funds in the Statement of Financial Position.
(in millions of dollars)
As at March 31, 2026
As at December 31, 2025
Assets
Cash and short-term investments
$ 1,057
$ 1,745
Bonds
7,859
7,679
Stocks and investment funds
55,339
54,264
Mortgages
92
86
Derivative financial instruments
–
1
Other assets
998
697
65,345
64,472
Liabilities
Accounts payable and accrued expenses
1,183
1,425
Derivative financial instruments
12
–
1,195
1,425
Net assets
$ 64,150
$ 63,047
The following table presents the change in segregated funds net assets:
Three months ended March 31
(in millions of dollars)
2026
2025
Balance at beginning
$ 63,047
$ 52,575
Add:
Amounts received from policyholders
3,686
3,210
Interest, dividends and other investment income
401
315
Change in fair value of investments
(314)
(431)
3,773
3,094
Less:
Amounts withdrawn by policyholders
2,357
1,771
Operating expenses
313
258
2,670
2,029
Balance at end
$ 64,150
$ 53,640
-
› Insurance Contracts and Reinsurance Contracts
-
Changes in Insurance Contract and Reinsurance Contract Balances
-
Roll-Forward of Net Insurance Contract Liabilities (Assets) by Measurement Component
The following tables disclose the reconciliation by measurement component for insurance contracts not measured under the premium allocation approach (PAA):
As at March 31, 2026
(in millions of dollars)
Balance at beginning
Estimates of present value of future cash flows
Risk adjustment for nonfinancial risk
Contractual
service
margin Total
Insurance contract liabilities
$ 23,692
$ 4,116
$ 6,927
$ 34,735
Insurance contract assets
(376)
35
261
(80)
Insurance contract liabilities related to segregated funds
46,365
–
–
46,365
Net insurance contract liabilities (assets) at beginning
69,681
4,151
7,188
81,020
Insurance service result
Changes that relate to current services
Contractual service margin recognized for services provided
–
–
(210)
(210)
Change in risk adjustment for non-financial risk for risk expired
–
(89)
–
(89)
Experience adjustments
(12)
–
–
(12)
Changes that relate to future services
Contracts initially recognized in the period
(300)
123
193
16
Changes in estimates that adjust the contractual service margin
(5)
(29)
34
–
Changes in estimates that result in losses and reversal of losses on onerous contracts
11
(3)
–
8
Changes that relate to past services
Changes to liabilities for incurred claims
4
(13)
–
(9)
(302)
(11)
17
(296)
Finance expenses (income) from insurance contracts
(197)
(9)
28
(178)
Amounts recognized in net income
(499)
(20)
45
(474)
Effect of change in exchange rates
12
9
11
32
Cash flows
1,158
–
–
1,158
Net insurance contract liabilities (assets) at end
$ 70,352
$ 4,140
$ 7,244
$ 81,736
Balance at end
Insurance contract liabilities
$ 23,178
$ 4,105
$ 6,978
$ 34,261
Insurance contract assets
(376)
35
266
(75)
Insurance contract liabilities related to segregated funds
47,550
–
–
47,550
Net insurance contract liabilities (assets) at end
$ 70,352
$ 4,140
$ 7,244
$ 81,736
Estimates
As at December 31, 2025 Risk
(in millions of dollars)
Balance at beginning
of present value of future cash flows
adjustment for nonfinancial risk
Contractual
service
margin Total
Insurance contract liabilities
$ 24,336
$ 3,896
$ 6,130
$ 34,362
Insurance contract assets
(492)
32
355
(105)
Insurance contract liabilities related to segregated funds
38,149
–
–
38,149
Net insurance contract liabilities (assets) at beginning
61,993
3,928
6,485
72,406
Insurance service result
Changes that relate to current services
Contractual service margin recognized for services provided
–
–
(782)
(782)
Change in risk adjustment for non-financial risk for risk expired
–
(350)
–
(350)
Experience adjustments
(110)
–
–
(110)
Changes that relate to future services
Contracts initially recognized in the year
(1,126)
457
721
52
Changes in estimates that adjust the contractual service margin
(859)
87
772
–
Changes in estimates that result in losses and reversal of losses on onerous contracts
40
(5)
–
35
Changes that relate to past services
Changes to liabilities for incurred claims
19
(28)
–
(9)
(2,036)
161
711
(1,164)
Finance expenses (income) from insurance contracts
5,718
84
22
5,824
Amounts recognized in net income
3,682
245
733
4,660
Effect of change in exchange rates
(36)
(23)
(33)
(92)
Cash flows
4,028
–
–
4,028
Contracts acquired in the year
14
1
3
18
Net insurance contract liabilities (assets) at end
$ 69,681
$ 4,151
$ 7,188
$ 81,020
Balance at end
Insurance contract liabilities
$ 23,692
$ 4,116
$ 6,927
$ 34,735
Insurance contract assets
(376)
35
261
(80)
Insurance contract liabilities related to segregated funds
46,365
–
–
46,365
Net insurance contract liabilities (assets) at end
$ 69,681
$ 4,151
$ 7,188
$ 81,020
As at March 31, 2026, the amount of net insurance contract liabilities (assets) measured under the PAA is $2,622 ($2,582 as at December 31, 2025).
-
Net Reinsurance Contract Assets (Liabilities) by Measurement Component
The following tables disclose the net reinsurance contract assets (liabilities) by measurement component for reinsurance contracts not measured under the PAA:
As at March 31, 2026
(in millions of dollars)
Estimates of present value of future cash flows
Risk adjustment for nonfinancial risk
Contractual
service
margin Total
Net reinsurance contract assets (liabilities)
Reinsurance contracts not measured under the PAA
Reinsurance contract assets
$ 1,062
$ 1,077
$ (519)
$ 1,620
Reinsurance contract liabilities
(65)
9
54
(2)
$ 997
$ 1,086
$ (465)
$ 1,618
Estimates
As at December 31, 2025 Risk
(in millions of dollars)
of present value of future cash flows
adjustment for nonfinancial risk
Contractual
service
margin Total
Net reinsurance contract assets (liabilities)
Reinsurance contracts not measured under the PAA
Reinsurance contract assets
$ 1,042
$ 1,084
$ (514)
$ 1,612
Reinsurance contract liabilities
(61)
9
52
–
$ 981
$ 1,093
$ (462)
$ 1,612
As at March 31, 2026, the amount of net reinsurance contract assets (liabilities) measured under the PAA is $1,715 ($1,675 as at December 31, 2025).
-
-
Insurance Revenue
Three months ended March 31
(in millions of dollars)
2026
2025
Contracts not measured under the PAA
Changes in liabilities for remaining coverage
Contractual service margin recognized for services provided
$ 210
$ 186
Change in risk adjustment for non-financial risk for risk expired
99
93
Expected incurred claims and other insurance service expenses
969
874
Recovery of insurance acquisition cash flows
197
147
1,475
1,300
Contracts measured under the PAA
541
526
$ 2,016
$ 1,826
-
Discount Rates
The following tables present discount rates applied to discounting of future cash flows based on the liquidity characteristics of the insurance contracts:
As at March 31, 2026
1 year
5 years
10 years
20 years
30 years
70 years
Canadian products
Least illiquid curve
2.78%
3.40%
4.15%
5.03%
5.04%
4.35%
Most illiquid curve
3.87%
4.61%
5.22%
5.75%
6.07%
5.15%
U.S. products
Least illiquid curve
4.48%
4.80%
5.34%
6.10%
6.24%
4.90%
Most illiquid curve
4.73%
5.05%
5.59%
6.35%
6.49%
5.15%
As at December 31, 2025
1 year
5 years
10 years
20 years
30 years
70 years
Canadian products
Least illiquid curve
2.56%
3.24%
4.08%
4.93%
4.93%
4.35%
Most illiquid curve
3.50%
4.39%
5.08%
5.62%
5.80%
5.15%
U.S. products
Least illiquid curve
4.03%
4.45%
5.05%
5.88%
6.05%
4.90%
Most illiquid curve
4.28%
4.70%
5.30%
6.13%
6.30%
5.15%
-
-
› Common Shares
The common shares issued by the Company are as follows:
As at March 31, 2026 As at December 31, 2025
(in millions of dollars, unless otherwise indicated)
Number (in thousands)
Amount
Number (in thousands)
Amount
Common shares
Balance at beginning
91,735
$ 1,514
93,403
$ 1,524
Shares issued on exercise of stock options
29
2
300
22
Shares redeemed and cancelled
(1,646)
(27)
(1,968)
(32)
Balance at end
90,118
$ 1,489
91,735
$ 1,514
Stock Option Plan
As at March 31, 2026, the number of outstanding stock options was 1,272,173 (1,149,634 as at December 31, 2025). For the three months ended March 31, 2026, the Company granted 151,689 stock options exercisable at $154.37 (162,000 stock options exercisable at $134.17 for the year ended December 31, 2025).
Normal Course Issuer Bid
With the approval of the Toronto Stock Exchange and the Autorité des marchés financiers (AMF), the Board of Directors authorized the Company to repurchase for cancellation, in the normal course of its activities, between November 14, 2025 and November 13, 2026, up to 4,607,178 common shares (4,694,894 common shares in the normal course issuer bid of 2024), representing approximately 5% of its 92,143,563 common shares issued and outstanding as at October 31, 2025. For the three months ended March 31, 2026, a total of 1,646,356 common shares (1,968,075 as at December 31, 2025) were repurchased and cancelled for a net cash amount of $261 ($294 as at December 31, 2025), of which $27 was recorded against common shares ($32 as at December 31, 2025) and $234 against retained earnings ($262 as at December 31, 2025). Taxes related to the redemption net of the issuance of common shares for a total of $5 were recognized in Retained earnings ($5 as at December 31, 2025).
Dividends
Three months ended March 31
2026
2025
(in millions of dollars, unless otherwise indicated)
Total
Per share (in dollars)
Total
Per share (in dollars)
Common shares
$ 90
$ 0.99
$ 84
$ 0.90
Dividends Declared and Not Recognized on Common Shares
A dividend of 1.1000 dollars per share was approved by the Board of Directors of the Company on May 5, 2026. This dividend was not recorded as a liability in these Financial Statements. This dividend will be paid on June 15, 2026 to the shareholders of record as of May 15, 2026, date on which it will be recognized in the retained earnings of the Company.
-
› Preferred Shares and Other Equity Instruments
The preferred shares and other equity instruments issued are as follows:
As at March 31, 2026 As at December 31, 2025
(in millions of dollars, unless otherwise indicated)
Number (in thousands)
Amount
Number (in thousands)
Amount
Preferred shares, Class A
Balance at beginning
400
$ 400
–
$ –
Shares issued – Series C
–
–
400
400
Balance at end
400
400
400
400
Other equity instruments – Subordinated debentures
Balance at beginning and at end
600
600
600
600
Total preferred shares and other equity instruments
1,000
$ 1,000
1,000
$ 1,000
Preferred Shares
Dividends Declared and Not Recognized
A dividend of 32.175 dollars per Class A – Series C preferred share was approved by the Board of Directors of the Company on May 5, 2026. This dividend was not recorded as a liability in these Financial Statements. This dividend will be paid on June 30, 2026 to the shareholders of record as of June 5, 2026, date on which it will be recognized in the retained earnings of the Company.
Other Equity Instruments
Distributions
For the three months ended March 31, 2026, distributions on other equity instruments for a total of $12 ($9 after tax) were recognized in Retained earnings
($12 ($9 after tax) for the three months ended March 31, 2025).
-
› Capital Management
Regulatory Requirements and Solvency Ratio
The Company is committed to respecting certain requirements of the guideline on capital adequacy requirements for life insurers (CARLI).
An updated version of CARLI, applicable prospectively, came into effect on January 1, 2026. As at December 31, 2025, the Company anticipated the application, as authorized by the AMF, of the sections related to exposure to domestic infrastructure, whether in the form of debt or equity.
According to CARLI, many items are included in the solvency ratio:
The available capital represents the total Tier 1 and Tier 2 capital, less other deductions prescribed by the AMF.
Tier 1 capital contains more permanent equity items and is primarily composed of equity attributable to common shareholders, preferred shares, other qualifying equity instruments and the contractual service margin. Goodwill and other intangible assets are deducted from this category.
Tier 2 capital, notably composed of subordinated debentures and various items, represents capital of lower quality than Tier 1 capital, but still qualifies as available capital in the calculation of the total ratio.
The surplus allowance is the value of the risk adjustment for non-financial risk included in insurance contract liabilities.
The eligible deposits are amounts related to unregistered reinsurance agreements, which are deposited in guarantee instruments.
The base solvency buffer is determined according to five risk categories, namely credit risk, market risk, insurance risk, segregated fund guarantee risk and operational risk. These risk components are calculated using various methods and consider the risks associated to asset and liability elements that are on and off the Statement of Financial Position. The base solvency buffer represents the sum of risk components minus some credits (for example, between-risk diversification and adjustable products) multiplied by a scalar of 1.00.
The CARLI total ratio is calculated by dividing the sum of the available capital, the surplus allowance and the eligible deposits by the base solvency buffer.
According to the AMF guideline, the Company must set a target level of available capital that exceeds the minimum requirements. The guideline also stipulates that most of the available capital must be Tier 1, which absorbs the losses related to current operations.
The Company manages its capital on a consolidated basis. As at March 31, 2026, the Company maintains a ratio that satisfies the regulatory requirements.
(in millions of dollars, unless otherwise indicated) As at March 31, 2026
Available capital
Tier 1 capital $ 6,325
Tier 2 capital 5,720
Surplus allowance and eligible deposits 3,083
Total $ 15,128
Base solvency buffer $ 11,311
Total ratio 134%
As at December 31, 2025, the solvency ratio was 133% and the Company maintained a ratio that satisfied the regulatory requirements.
-
› Income Taxes
Income tax expense (recovery) for the period consists of:
Three months ended March 31
(in millions of dollars, unless otherwise indicated)
2026
2025
Current income tax expense (recovery)
$ 127
$ 116
Deferred income tax expense (recovery)
(26)
(70)
$ 101
$ 46
Effective Income Tax Rate
The effective income tax rate for the three months ended March 31, 2026 differs from the Company’s statutory income tax rate of 28%, mainly due to the impact of tax legislation changes enacted during the quarter.
For the three months ended March 31, 2026, the effective income tax rate was 41% in comparison to 19% for the three months ended March 31, 2025. This increase is mainly due to the unfavourable impact of tax legislation changes enacted during the quarter and lower tax savings from tax-exempt investment income, partially offset by lower adjustments related to prior years compared to the three months ended March 31, 2025.
-
› Segmented Information
The Company offers its products and services to retail customers, businesses and groups and primarily operates in Canada and in the United States. The Company’s business units are grouped into reportable operating segments based on their similar economic characteristics. The Company’s operating segments, which reflect its organizational structure for decision making, are described below according to their main products and services or to their specific characteristics:
Insurance, Canada – Life and health insurance products, auto and home insurance products, creditor insurance, replacement insurance and warranties, extended warranties and other ancillary products for dealer services, and specialized products for special markets.
Wealth Management – Products and services for savings plans, retirement funds and segregated funds, in addition to securities brokerage (including cross-border services), trust operations and mutual funds.
US Operations – Life insurance products and extended warranties relating to dealer services sold in the United States. Investment – Investment and financing activities of the Company, except the investment activities of wealth distribution affiliates. Corporate – All expenses that are not allocated to other operating segments, such as expenses for certain corporate functions.
Inter-segment transactions as well as some adjustments related to consolidation are shown in the Consolidation adjustments column. Inter-segment transactions consist primarily of activities carried out in the normal course of business for those operating segments and are subject to normal market conditions.
Considering the Company’s total portfolio management strategy, most of the Company’s investments are allocated to the Investment segment. When assessing segmented performance, management allocates Finance income (expenses) from insurance contracts, Finance income (expenses) from reinsurance contracts and nearly all (Increase) decrease in investment contract liabilities and interest on deposits to this operating segment.
Segmented Results
Three months ended March 31, 2026
(in millions of dollars)
Insurance, Canada
Wealth Management
US
Operations
Investment
Corporate
Consolidation adjustments
Total
Insurance service result
Insurance revenue
$ 1,127
$ 377
$ 512
$
–
$
–
$
–
$ 2,016
Insurance service expenses and net expenses from reinsurance contracts
(988)
(260)
(463)
–
–
–
(1,711)
139
117
49
–
–
–
305
Net investment result
Net investment income
–
41
–
(121)
(8)
–
(88)
Finance income (expenses) from insurance and
reinsurance contracts and change in investment
contract liabilities and interest on deposits
–
(2)
–
190
–
–
188
–
39
–
69
(8)
–
100
Other revenues
55
543
46
9
1
(26)
628
Other expenses
(69)
(542)
(74)
(62)
(65)
26
(786)
Income before income taxes
125
157
21
16
(72)
–
247
Income tax (expense) recovery
(37)
(43)
(5)
(35)
19
–
(101)
Net income
88
114
16
(19)
(53)
–
146
Dividends on preferred shares and distributions
on other equity instruments
–
–
–
(9)
–
–
(9)
Net income attributed to common shareholders
$ 88
$ 114
$ 16
$ (28)
$ (53)
$ –
$ 137
Three months ended March 31, 2025
(in millions of dollars)
Insurance, Canada
Wealth Management
US
Operations
Investment
Corporate
Consolidation adjustments
Total
Insurance service result
Insurance revenue $ 1,049
$ 307
$ 470
$ –
$ –
$ –
$ 1,826
Insurance service expenses and net expenses from reinsurance contracts
(913)
(211)
(421)
–
–
–
(1,545)
136
96
49
–
–
–
281
Net investment result
Net investment income
–
26
–
436
1
–
463
Finance income (expenses) from insurance and
reinsurance contracts and change in investment
contract liabilities and interest on deposits
–
–
–
(357)
–
–
(357)
–
26
–
79
1
–
106
Other revenues
52
390
53
9
2
(19)
487
Other expenses
(60)
(380)
(78)
(64)
(70)
19
(633)
Income before income taxes
128
132
24
24
(67)
–
241
Income tax (expense) recovery
(41)
(37)
(5)
20
17
–
(46)
Net income
87
95
19
44
(50)
–
195
Distributions on other equity instruments
–
–
–
(9)
–
–
(9)
Net income attributed to common shareholders
$ 87
$ 95
$ 19
$ 35
$ (50)
$ –
$ 186
-
› Earnings Per Common Share
Basic Earnings Per Share
Basic earnings per share are calculated by dividing the net income attributed to common shareholders by the weighted average number of outstanding common shares during the period.
Three months ended March 31
(in millions of dollars, unless otherwise indicated)
2026
2025
Net income attributed to common shareholders
$ 137
$ 186
Weighted average number of outstanding shares (in millions of units)
91
93
Basic earnings per share (in dollars)
$ 1.50
$ 1.99
Diluted Earnings Per Share
Diluted earnings per share are calculated by adjusting the weighted average number of outstanding common shares to take into account the conversion of all potentially dilutive common shares.
The dilutive effect of stock options considers the number of shares presumed issued without consideration, calculated as the difference between the number of shares deemed to have been issued (by assuming the outstanding stock option grants are exercised) and the number of shares that would have been issued at the average market price for the period (the number of shares that would have been issued using the issuance proceeds, using the average market price of the Company’s common shares for the period). For the three months ended March 31, 2026, an average of 23,379 antidilutive stock options (35,452 for the three months ended March 31, 2025) were excluded from the calculation.
Three months ended
March 31
(in millions of dollars, unless otherwise indicated)
2026
2025
Net income attributed to common shareholders
$ 137
$ 186
Weighted average number of outstanding shares (in millions of units)
91
93
Add: dilutive effect of stock options granted and outstanding (in millions of units)
1
1
Weighted average number of outstanding shares on a diluted basis (in millions of units)
92
94
Diluted earnings per share (in dollars)
$ 1.49
$ 1.98
There was no transaction on common shares that could affect these calculations after the closing date and before the date of authorization for issue of these Financial Statements.
-
› Commitments
Investment Commitments
In the normal course of the Company’s business, various outstanding contractual commitments related to offers for commercial loans, private placements, joint ventures and real estate are not reflected in the financial statements and may not be fulfilled. There were $2,138 ($2,166 as at December 31, 2025) of outstanding commitments as at March 31, 2026, of which the estimated disbursements will be $128 ($127 as at December 31, 2025) in 30 days, $497 ($480 as at December 31, 2025) in 31 to 365 days and $1,513 ($1,559 as at December 31, 2025) in more than one year.
-
› Event After the Reporting Period
Amendment to Normal Course Issuer Bid
With the approval of the Toronto Stock Exchange and the AMF, the Board of Directors has authorized the Company, on May 5, 2026, to amend its current normal course issuer bid in order to increase the maximum number of common shares that may be repurchased for cancellation thereunder from 4,607,178 common shares, representing approximately 5% of the Company’s 92,143,563 common shares issued and outstanding as at October 31, 2025, to 7,371,485 common shares, representing approximately 8% of the 92,035,190 common shares that constituted the Company’s “public float” as at October 31, 2025. No other terms of the normal course issuer bid have been amended.
-
› Comparative Figures
Certain comparative figures have been reclassified to comply with the current period’s presentation. The reclassifications had no impact on the net income of the Company.
Attachments
- Original document
- Permalink
Disclaimer
iA Financial Corporation Inc. published this content on May 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 05, 2026 at 22:20 UTC.
iA Financial Corporation Inc. is a holding company, which offers a range of life and health insurance products and other financial products and services. The Company’s segments include Insurance, Canada; Wealth Management; US Operations; Investment, and Corporate. The Insurance, Canada segment includes life and health insurance products, auto and home insurance products, creditor insurance, replacement insurance and warranties, extended warranties and other ancillary products for dealer services, and specialized products for special markets. It also engaged in offering Final Expense and Term Life products. Wealth Management segment includes products and services for savings plans, retirement funds and segregated funds, in addition to securities brokerage (including cross-border services), trust operations and mutual funds. Its US Operations segment includes life insurance products and extended warranties relating to dealer services sold in the United States.

Buy
Last Close Price
159.21CAD
Average target price
179.14CAD
Spread / Average Target
+12.52%
Select your edition
All financial news and data tailored to specific country editions
